Provident Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.7M | Buy |
158,707
+2,382
| +2% | +$1.06M | 6.04% | 4 |
|
|
2025
Q1 | $75.8M | Buy |
156,325
+1,259
| +0.8% | +$610K | 7.14% | 2 |
|
|
2024
Q4 | $62.4M | Sell |
155,066
-439
| -0.3% | -$177K | 5.96% | 7 |
|
|
2024
Q3 | $72.3M | Sell |
155,505
-4,357
| -3% | -$2.03M | 6.45% | 3 |
|
|
2024
Q2 | $74.9M | Sell |
159,862
-263
| -0.2% | -$123K | 6.82% | 3 |
|
|
2024
Q1 | $66.9M | Sell |
160,125
-194
| -0.1% | -$81.1K | 5.9% | 5 |
|
|
2023
Q4 | $65.2M | Sell |
160,319
-850
| -0.5% | -$346K | 6.16% | 4 |
|
|
2023
Q3 | $56M | Sell |
161,169
-1,060
| -0.7% | -$369K | 6.18% | 5 |
|
|
2023
Q2 | $57.1M | Sell |
162,229
-815
| -0.5% | -$287K | 6.04% | 4 |
|
|
2023
Q1 | $51.4M | Buy |
163,044
+2,317
| +1% | +$730K | 5.57% | 5 |
|
|
2022
Q4 | $46.4M | Sell |
160,727
-1,300
| -0.8% | -$375K | 5.5% | 5 |
|
|
2022
Q3 | $46.9M | Sell |
162,027
-7,328
| -4% | -$2.12M | 6.01% | 3 |
|
|
2022
Q2 | $47.7M | Sell |
169,355
-17,959
| -10% | -$5.06M | 5.62% | 4 |
|
|
2022
Q1 | $48.9M | Buy |
187,314
+2,135
| +1% | +$557K | 4.68% | 9 |
|
|
2021
Q4 | $40.7M | Buy |
185,179
+1,813
| +1% | +$398K | 3.67% | 16 |
|
|
2021
Q3 | $33.3M | Buy |
183,366
+6,531
| +4% | +$1.18M | 3.18% | 20 |
|
|
2021
Q2 | $35.7M | Buy |
+176,835
| New | +$35.7M | 3.44% | 19 |
|